PapersPMID:32665012
The effects of green coffee extract supplementation on glycemic indices and lipid profile in adults: a systematic review and dose-response meta-analysis of clinical trials.
- findings
- 5
- compound
- 1
- endpoints
- 5
- no difference found
- 3
- Study, every finding
- meta-analysis
- Dose studied, every finding
- GCE 90 to 6000 mg/day, CGA 13.5 to 1200 mg/day
- Population, every finding
- Adults (18 years and over) in placebo-controlled trials of green coffee extract lasting at least 2 weeks; participants healthy or overweight, obese, dyslipidaemic, hypertensive, with metabolic syndrome, fatty liver, impaired glucose tolerance or xerotic skin
What moved
How to read these marks →- Decreases fasting blood glucose
moderate
“After combining effect sizes, we found a significant reducing effect of GCE supplementation on FBG levels (WMD: -2.35, 95% CI: − 3.78, − 0.92 mg/dL, P = 0.001).”
- Effect
- −2.35 mean difference, 95% CI −3.78 to −0.92
- Decreases total cholesterol (TC)
moderate
“Combining these effect sizes, a significant reduction was seen in serum concentrations of TC following GCE supplementation (WMD: -4.51, 95% CI: − 8.39, − 0.64 mg/dL, P = 0.02).”
- Effect
- −4.51 mean difference, 95% CI −8.39 to −0.64
What did not
“Considering 15 effect sizes from 12 studies which included 642 participants, no significant effect of GCE supplementation on serum concentrations of LDL was found (WMD: -2.02, 95% CI: − 5.58, 1.54 mg/dL, P = 0.26, I 2: 47.6, P = 0.02).”
- Participants
- 642
- Effect
- −2.02 mean difference, 95% CI −5.58 to 1.54
“Combining 15 effect sizes from these studies revealed no significant effect of GCE supplementation on serum TG concentrations (WMD: -3.17, 95% CI: − 11.82, 5.49 mg/dL, P = 0.47).”
- Effect
- −3.17 mean difference, 95% CI −11.82 to 5.49
“Combining 15 effect sizes from these studies revealed no significant effect of GCE supplementation on HDL levels (WMD: 1.08, 95% CI: − 0.22, 2.38 mg/dL, P = 0.10).”
- Effect
- 1.08 mean difference, 95% CI −0.22 to 2.38
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Adults (18 years and over) in placebo-controlled trials of green coffee extract supplementation, healthy or with overweight, obesity, dyslipidemia, hypertension, metabolic syndrome, NAFLD, impaired glucose tolerance or xerotic skin
- Participants
- 766
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 23